1490 studies found for:    "Mayo Clinic" [Exact]
Show Display Options
Rank Status Study
1 Enrolling by invitation Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle
Condition: Pancreatic Cancer
Interventions: Device: Fine Needle Biopsy (FNB);   Device: Fine Needle Aspiration (FNA)
2 Not yet recruiting Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children
Conditions: Pregnancy;   Autistic Disorder;   Folic Acid Deficiency
Intervention: Dietary Supplement: Prenatal supplement
3 Active, not recruiting Employee Wellness Survey
Condition: Tobacco Use
Intervention:
4 Not yet recruiting MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
Conditions: Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Lung Cancer;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Metastatic Cancer to the Lung
Intervention: Procedure: Microwave ablation
5 Not yet recruiting Disulfiram and Gemcitabine Hydrochloride in Treating Patients With Unresectable Solid Tumors or Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Solid Neoplasm;   Stage IV Pancreatic Cancer
Interventions: Drug: Disulfiram;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Placebo
6 Not yet recruiting Stress Management Intervention in Women's Heart Clinic, Heart SMART Program
Condition: Stress
Interventions: Behavioral: Face to Face Heart SMART Program;   Behavioral: On-line Heart SMART Program;   Behavioral: Mayo Clinic Guide to Stress Free Living
7 Recruiting Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Condition: Recurrent Plasma Cell Myeloma
Interventions: Drug: Bortezomib;   Drug: Dexamethasone;   Drug: Dinaciclib;   Other: Laboratory Biomarker Analysis
8 Not yet recruiting WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Chronic Myelomonocytic Leukemia;   Myelodysplastic Syndrome With Isolated Del(5q);   Myelodysplastic/Myeloproliferative Neoplasm;   Previously Treated Myelodysplastic Syndrome;   Recurrent Adult Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: WEE1 Inhibitor AZD1775
9 Not yet recruiting Assessing the Comparability of 2D and 4D Ultrasound Measurements
Condition: Carpal Tunnel
Interventions: Procedure: 4D Ultrasound;   Procedure: 2D ultrasound
10 Recruiting Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts
Condition: Bidirectional Cardiovascular Shunt
Interventions: Procedure: Transesophageal Echocardiogram (TEE);   Procedure: Transthoracic Echocardiogram (TTE);   Other: Saline/Air Mixture;   Other: Saline/Blood Mixture
11 Recruiting Spinal Stimulation During Exercise in Heart Failure
Condition: Heart Failure
Intervention: Device: Precision Spinal Cord Stimulator System
12 Not yet recruiting Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal or Endometrial Cancer
Conditions: Estrogen Receptor Positive;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Uterine Corpus Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Drug: Ribociclib
13 Recruiting Root Coverage Using a Xenograph for Treatment of Gingival Recession
Condition: Localized Gingival Recession
Intervention: Device: PriMatrix
14 Not yet recruiting Use of F-652 in Patients With Alcoholic Hepatitis
Condition: Alcoholic Hepatitis
Intervention: Drug: F-652
15 Active, not recruiting Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Conditions: Recurrent Thyroid Gland Carcinoma;   Stage III Differentiated Thyroid Gland Carcinoma;   Stage III Thyroid Gland Medullary Carcinoma;   Stage IVA Differentiated Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Medullary Carcinoma;   Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;   Stage IVB Differentiated Thyroid Gland Carcinoma;   Stage IVB Thyroid Gland Medullary Carcinoma;   Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;   Stage IVC Differentiated Thyroid Gland Carcinoma;   Stage IVC Thyroid Gland Medullary Carcinoma;   Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;   Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride
16 Recruiting Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-Cell Lymphoma;   Adult T-Cell Leukemia/Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-Cell Lymphoma;   B Lymphoblastic Leukemia/Lymphoma;   Blastic Plasmacytoid Dendritic Cell Neoplasm;   Burkitt Leukemia;   Central Nervous System Lymphoma;   Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma;   Diffuse Large B-Cell Lymphoma;   Enteropathy-Associated T-Cell Lymphoma;   Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue;   Grade 1 Follicular Lymphoma;   Grade 2 Follicular Lymphoma;   Grade 3 Follicular Lymphoma;   Hepatosplenic T-Cell Lymphoma;   Hodgkin Lymphoma;   Lymphoplasmacytic Lymphoma;   Mantle Cell Lymphoma;   Mediastinal (Thymic) Large B-Cell Lymphoma;   Mycosis Fungoides;   Nasal Type Extranodal NK/T-Cell Lymphoma;   Nodal Marginal Zone Lymphoma;   Peripheral T-Cell Lymphoma, Not Otherwise Specified;   Post-Transplant Lymphoproliferative Disorder;   Primary Cutaneous Anaplastic Large Cell Lymphoma;   Primary Effusion Lymphoma;   Sezary Syndrome;   Splenic Marginal Zone Lymphoma;   Subcutaneous Panniculitis-Like T-Cell Lymphoma;   Systemic Anaplastic Large Cell Lymphoma;   T Lymphoblastic Leukemia/Lymphoma;   Transformed Recurrent Non-Hodgkin Lymphoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Dietary Supplement: Salvia hispanica Seed
17 Not yet recruiting Hematopoietic Stem Cell Transplant Survivors Study (HTSS Study)
Condition: Stem Cell Transplant
Interventions: Drug: Quercetin;   Other: Standard of Care - Observation Only;   Drug: Dasatinib
18 Not yet recruiting TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
Conditions: Adult Solid Neoplasm;   Colorectal Adenocarcinoma;   Metastatic Pancreatic Adenocarcinoma;   Recurrent Breast Carcinoma;   Recurrent Colorectal Carcinoma;   Recurrent Melanoma of the Skin;   Recurrent Non-Small Cell Lung Carcinoma;   Recurrent Pancreatic Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Breast Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Renal Cell Cancer;   Stage IV Skin Melanoma;   Stage IVA Colorectal Cancer;   Stage IVA Pancreatic Cancer;   Stage IVB Colorectal Cancer;   Stage IVB Pancreatic Cancer
Interventions: Drug: Cyclophosphamide;   Other: Laboratory Biomarker Analysis;   Biological: Pegfilgrastim;   Drug: TLR8 Agonist VTX-2337
19 Not yet recruiting Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy
Conditions: Stage I Chronic Lymphocytic Leukemia;   Stage II Chronic Lymphocytic Leukemia;   Stage III Chronic Lymphocytic Leukemia;   Stage IV Chronic Lymphocytic Leukemia
Interventions: Drug: Ibrutinib;   Other: Laboratory Biomarker Analysis
20 Recruiting Staging Procedures to Diagnose Malignant Pleural Mesothelioma
Conditions: Mesothelioma;   Solitary Fibrous Tumor of the Pleura
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years